Filter
1650
Text search:
hazards
Featured
160
429
Language
Document type
842
297
208
130
77
30
28
21
12
2
2
1
Countries / Regions
85
79
54
53
36
32
31
27
25
23
22
21
19
18
18
17
16
15
15
15
14
14
13
13
12
11
10
9
9
9
9
9
9
8
8
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
560
143
97
67
41
34
25
8
2
1
Toolboxes
193
124
110
108
97
63
58
55
48
46
45
39
34
29
27
25
22
10
8
5
3
2
2
2
2
“towards quality health and social welfare services”
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Research Article
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002625 July 31, 2018 / 1-19
Accessed November, 2017
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
PMPB/INS-GUIDE/02
Therapeutics Information and Pharmacovigilance Centre | TIPC
